Advances in the treatment of multiple myeloma: the role of thalidomide

Advances in the treatment of multiple myeloma: the role of thalidomide

Author Ribas, Christian Autor UNIFESP Google Scholar
Colleoni, Gisele Wally Braga Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Abstract Multiple myeloma (MM) accounts for 1% of all malignancies and 10% of malignant hematological neoplasms. in spite of high-dose therapy with stem cell rescue, relapse and disease resistance are common events in the course of the disease. Thalidomide (Thal) has been successfully used in such situations and it's use has also been expanded to the up-front therapy and as adjuvant to stem cell transplantation. Here, we review the underlying concepts and current clinical data regarding Thal in the treatment of MM.
Keywords multiple myeloma
thalidomide
treatment
review
Language English
Date 2003-01-01
Published in Leukemia & Lymphoma. Abingdon: Taylor & Francis Ltd, v. 44, n. 2, p. 291-298, 2003.
ISSN 1042-8194 (Sherpa/Romeo, impact factor)
Publisher Taylor & Francis Ltd
Extent 291-298
Origin http://dx.doi.org/10.1080/1042819021000035671
Access rights Closed access
Type Article
Web of Science ID WOS:000179633700012
URI http://repositorio.unifesp.br/handle/11600/27102

Show full item record




File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account